Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Pacira Biosciences	Akcea Therapeutics	Dicerna Pharmaceuticals	Theravance Biopharma	Karyopharm Therapeutics
Symbol	NASDAQ:PCRX	NASDAQ:AKCA	NASDAQ:DRNA	NASDAQ:TBPH	NASDAQ:KPTI
Price Information
Current Price	$43.95	$14.90	$21.57	$25.25	$18.80
52 Week Range	Buy	Buy	Buy	Buy	Buy
Beat the Market™ Rank
Overall Score	1.6	1.2	1.7	1.5	1.8
Analysis Score	3.3	3.4	4.5	3.4	4.4
Community Score	2.8	2.4	3.0	2.4	3.0
Dividend Score	0.0	0.0	0.0	0.0	0.0
Ownership Score	0.0	0.0	1.0	1.0	1.0
Earnings & Valuation Score	1.9	0.0	0.0	0.6	0.6
Analyst Ratings
Consensus Recommendation	Buy	Buy	Buy	Buy	Buy
Consensus Price Target	$54.50	$34.67	$34.20	$37.00	$30.63
% Upside from Price Target	24.00% upside	132.66% upside	58.55% upside	46.53% upside	62.90% upside
Trade Information
Market Cap	$1.88 billion	$1.51 billion	$1.59 billion	$1.58 billion	$1.36 billion
Beta	1.31	1.33	1.84	1.54	1.6
Average Volume	656,282	246,036	673,564	392,463	1,655,896
Sales & Book Value
Annual Revenue	$421.03 million	$488.54 million	$23.90 million	$73.41 million	$40.89 million
Price / Sales	4.40	3.08	66.71	21.70	33.62
Cashflow	$1.70 per share	$0.50 per share	N/A	N/A	N/A
Price / Cash	25.86	29.55	N/A	N/A	N/A
Book Value	$8.88 per share	$5.04 per share	$2.41 per share	($2.50) per share	$2.27 per share
Price / Book	4.95	2.96	8.95	-10.10	8.28
Profitability
Net Income	$-11,020,000.00	$40.77 million	$-120,460,000.00	$-236,460,000.00	$-199,590,000.00
EPS	$0.86	$0.48	($1.76)	($4.25)	($3.22)
Trailing P/E Ratio	N/A	N/A	N/A	N/A	N/A
Forward P/E Ratio	22.77	N/A	N/A	N/A	N/A
P/E Growth	$1.50	N/A	N/A	N/A	N/A
Net Margins	-0.02%	-8.59%	-213.04%	-280.80%	-316.53%
Return on Equity (ROE)	13.89%	-6.70%	-74.79%	N/A	-208.07%
Return on Assets (ROA)	6.06%	-5.92%	-22.53%	-47.43%	-59.78%
Dividend
Annual Payout	N/A	N/A	N/A	N/A	N/A
Dividend Yield	N/A	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	0.94%	0.03%	0.12%	N/A	0.75%
Current Ratio	5.37%	12.63%	2.90%	5.45%	7.46%
Quick Ratio	4.63%	12.25%	2.90%	5.45%	7.44%
Ownership Information
Institutional Ownership Percentage	N/A	20.15%	82.78%	88.47%	96.14%
Insider Ownership Percentage	5.80%	1.50%	21.28%	5.90%	13.26%
Miscellaneous
Employees	518	248	78	363	332
Shares Outstanding	42.12 million	101.07 million	73.92 million	63.09 million	73.12 million
Next Earnings Date	8/13/2020 (Estimated)	8/4/2020 (Estimated)	8/13/2020 (Estimated)	7/29/2020 (Estimated)	8/4/2020 (Estimated)
Optionable	Optionable	Optionable	Optionable	Optionable	Optionable

Comparison Ideas:

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

Start Your Free Trial Today

Market Data and Calendars

Investing Education and Resources